Ranaz reports its results for the third quarter of 2010

MONTREAL, Nov. 30 /CNW/ -- 
    --  Increase of the net earnings of $883,325 as compared to the
        third quarter of 2009 and $671,796 as compared to the
        nine-month period ended September 30, 2009
    --  Increase of the adjusted operating earnings of $736,842 as
        compared to the third quarter of 2009 and $1,191,940 as
        compared to the nine-month period ended September 30, 2009



MONTREAL, Nov. 30 /CNW Telbec/ - Ranaz Corporation ("Ranaz") (TSX-V:
 RNZ), a company specializing in the manufacturing and marketing of
 protein and dietary supplements, reported its results today for the
 third quarter ended September 30, 2010.


Ranaz's main focus for the balance of fiscal 2010 is to continue to
 streamline its production costs and operating expenses. As indicated by
 the results, the gross margin for the first nine months of 2010
 represents 31.5% as compared to 26.4% for the same period of 2009. This
 increase of the margin reflects the efforts in the reduction of costs.
 The operating expenses for the nine-month period ended September 30,
 2010 totalled $3,531,385 as compared to $ 4,315,237 for the same period
 of 2009, a direct effect of Ranaz's better control of the expenses.


In the next quarters, the Company will now focus on specific strategies
 to increase sales, and will continue to accentuate the development of
 new customers in all of its markets.


Mr. Aldo Spensieri joined Ranaz Corporation as Vice President of Sales
 and Marketing effective November 5, 2010. Mr. Spensieri was previously
 employed by West Point Products as their Vice President of Sales Canada
 and Vice President of Corporate Marketing. He has been involved in the
 manufacturing industry for close to 25 years. He has been instrumental
 in the development and successful implementation of WPP's award
 nominated Axess Managed Print Services Program.


Since Mr. Spensieri joined Ranaz, his priority has been to analyze and
 establish, with the current executive team, a sales and marketing
 strategy for 2011. Ranaz will review its marketing strategy to focus on
 brand to minimize channel conflicts within the brands and maximize both
 exposure and sales to the identified channels chosen for the brands.
 More in depth sales and marketing initiatives will be announced shortly
 for each of the brands, namely Protidiet, ProtiLife and Private Label.
 The objective of this brand focused strategy will be to increase
 Ranaz's sales.


In the wake of the success of Ranaz's new manufacturing bar line, it has
 launched 2 new bars in the ProtiLife brand as well 3 new products for
 the Protidiet brand.


Sales for the third quarter of 2010 totalled $4,2 million as compared to $4,6
 million in the same quarter of 2009, decrease of $0,4 million or 9.8%. Sales for the first nine months of 2010 totalled $13,5 million, down of $1,1
 million or 7.6% as compared to the same period of 2009. The sales for
 Protidiet and ProtiLife are virtually unchanged for the 2010 periods as
 compared to the 2009 periods presented. The sales for the bar line
 private label decreased because during the transition period in 2009,
 the Company took that opportunity to eliminate the low margin products.
 This elimination has a temporary negative impact on sales but a
 positive impact in gross margin.


Gross profit totalled $1,3 million for the three-month period ended September 30,
 2010 as compared to $1,0 million for the same quarter of 2009, and
 represented 30.1% and 22.3% of sales respectively for these quarters
 (gross margin). For the nine-month period ended September 30, 2010, gross profit was $4,3 million or 31,5% of sales compared to $3,9 million or 26.4% of
 sales for the same period in 2009. Since the beginning of 2010, the
 Company has a better control on the production costs and the effort to
 increase the productivity level begins to give dividends. The nominal
 increase in gross margin percentage for the third quarter of 2010
 compared to 2009 and the first nine months of 2010 as compared to the
 same period of 2009 was also due to change in product and market sales
 mix.


The net earnings for the quarter ended September 30, 2010 amounted to
 $183,505 or $0.003 per share, compared to a net loss of $699,820 or
 $0.014 per share for the third quarter of 2009 representing an increase
 of 126.2%. The net earnings for the nine-month period ended September 30, 2010 was $149,838 or
 $0.002 per share compared to a net loss of $521,958 or $0.011 per share
 for the first nine months of 2009.


The adjusted operating earnings for the quarter ended September 30, 2010
 amounted to $310,530 or $0.005 per share, compared to an adjusted
 operating loss of $428,150 or $0.008 per share for the third quarter of
 2009 representing a growth of 172.5%. The adjusted operating earnings
 for the first nine-month period ended September 30, 2010 amounted to
 $735,134 or $0.012 per share, compared to an adjusted operating loss of
 $454,970 or $0.010 per share for the nine months period ended September
 30, 2009 representing a growth of 261.6%.


About Ranaz Corporation


Ranaz is a corporation specializing in the manufacture and marketing of
 protein and dietary supplements. Its mission is to design, develop and
 market nutritional, protein and dietary supplements under its own
 corporate brands and concepts, such as Protidiet and ProtiLife, as well
 as under private labels.


Full information, including the management discussion and analysis and
 the financial statements and notes thereto, is available on SEDAR, at www.sedar.com.


Neither TSX Venture Exchange nor its Regulation Services Provider (as
 that term is defined in the policies of the TSX Venture Exchange)
 accepts responsibility for the adequacy or accuracy of this release.




table valign="top" border="0"trtdbRanaz Corporation/bbr/ Paul Guay, CA    br/ Chief Financial Officer   br/ [phone], poste 200   br/ a href="mailto:[e-mail]"[e-mail]/aa href="mailto:[e-mail]"m/a  /td tdbRanaz Corporation/bbr/ Jean Bourassa Marineaubr/ President and CEObr/ [phone], poste 217br/  /td/tr/table

Copyright